SCHEMBL3373446

SCHEMBL3373446

CCC(C)NC(=O)c1c(OS(=O)(=O)C(F)(F)F)cccc1C(=O)O

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.45
KMT2A Q03164 2/20 0.45
PKM P14618 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
ALDH1A1 P00352 2/20 0.40
RAB9A P51151 1/20 0.40
DRD2 P14416 5/20 0.39
DRD3 P35462 4/20 0.39
HTR1D P28221 2/20 0.39
HPGD P15428 2/20 0.38
CA12 O43570 1/20 0.37
CA1 P00915 1/20 0.37
CA2 P00918 1/20 0.37
CA9 Q16790 1/20 0.37
DRD4 P21917 2/20 0.36
HTR5A P47898 1/20 0.36
MAPK1 P28482 1/20 0.36
FPR1 P21462 1/20 0.36
KDM4E B2RXH2 1/20 0.36
HSD17B10 Q99714 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3373454 0.91 MEN1 (0.48) MEN1KMT2APKMSMN1; SMN2ALDH1A1
SCHEMBL3379105 0.90 NPSR1 (0.40) ALDH1A1DRD2DRD3HTR1DHPGD
SCHEMBL3377672 0.90 DRD2 (0.35) MEN1KMT2AALDH1A1RAB9ADRD2
SCHEMBL3377825 0.87 MEN1 (0.48) MEN1KMT2APKMSMN1; SMN2ALDH1A1
SCHEMBL3377852 0.87 MEN1 (0.48) MEN1KMT2APKMSMN1; SMN2ALDH1A1
SCHEMBL3376132 0.84 POLB (0.43) MEN1KMT2ASMN1; SMN2DRD2DRD3
SCHEMBL3377416 0.82 DRD2 (0.47) MEN1KMT2AALDH1A1DRD2DRD3
SCHEMBL3377677 0.81 MEN1 (0.37) MEN1KMT2AALDH1A1RAB9ADRD2
SCHEMBL3379111 0.81 NPSR1 (0.40) ALDH1A1DRD2HPGDCA12CA1
SCHEMBL3377816 0.81 KMT2A (0.39) MEN1KMT2AALDH1A1DRD2DRD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1517886-B1 NOVEL PHTHALAMIDE DERIVATIVES BAYER CROPSCIENCE AG (DE) 2010-11-10 EP disclosed
US-7132455-B2 Phthalamide derivatives BAYER CROPSCIENCE AG (DE) 2006-11-07 US disclosed
US-20060035967-A1 Novel phthalamide derivatives BAYER INTELLECTUAL PROPERTY GMBH (DE) 2006-02-16 US disclosed
EP-1517886-A1 NOVEL PHTHALAMIDE DERIVATIVES Bayer CropScience AG (DE) 2005-03-30 EP disclosed
WO-2004000796-A1 NOVEL PHTHALAMIDE DERIVATIVES BAYER CROPSCIENCE AG (DE) 2003-12-31 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060035967-A1 Novel phthalamide derivatives HDAC1, HDAC2, CRY1 MEN1 1772/4885KMT2A 102/4885PKM 1543/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.